# Reese Pharmaceutical Company – FDA Inspection, Nov 24, 2010

Source: https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/c38ba460-7d5d-4a11-9b53-72a375e880e5
Source feed: FDA_Inspections

> FDA inspection 697501 of Reese Pharmaceutical Company, November 24, 2010. Classification: Official Action Indicated (OAI). 16 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 697501
- Company Name: Reese Pharmaceutical Company
- Inspection Date: 2010-11-24
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 16

## Related Documents

- FDA Inspection 1287906 - 2025-09-25
- FDA Inspection 1160702 - 2021-12-09
- FDA Inspection 1160701 - 2021-12-08
- FDA Inspection 1017672 - 2017-06-05
- FDA Inspection 1012578 - 2017-04-25

Company: https://www.keypedia.com/companies/reese-pharmaceutical-company/8eb10f05-b060-421f-a56f-22fbb96e4a97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c